Printer Friendly
The Free Library
14,380,416 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Asahi Kasei Medical, Kuraray Medical to Jointly Set up Hollow Fiber Membrane Manufacturing Company.


Tokyo, Japan, June 5, 2006 - (JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
) - Asahi Kasei Medical announced on June 1 that it has reached a basic agreement with Kuraray Medical to establish a 50-50 joint venture company for manufacturing hollow fiber membranes with a view to ensuring a stable supply of blood purification and dialysis devices.

To be capitalized at 490 million yen ($4.4 mil), A-K Membrane Manufacturing Co., Ltd. will be located in Miyazaki and will manufacture and distribute hollow fiber membranes using EVAL, Kuraray's proprietary ethylene ethylene (ĕth`əlēn') or ethene (ĕth`ēn), H2C=CH2, a gaseous unsaturated hydrocarbon. It is the simplest alkene.  vinyl alcohol copolymer copolymer: see polymer.  (EVOH EVOH Ethylene Vinyl Alcohol Polymer (chemical industry)  resin).

The joint venture will invest 2.5 billion yen ($22.5 mil) in plant and equipment and start full-scale operations in May 2008.

The plant will start with an annual output capacity of 2.6 million units and increase to 4.0 million units.

Copyright [c] 2006 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2006 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Jun 6, 2006
Words:141
Previous Article:Takara Bio to Release Two New Enzymes.
Next Article:Mitsui Acquires Salt Field in Western Australia.



Related Articles
Asahi Kasei, NTT Solmare Collaborate on Diet Analysis Service.
Asahi Kasei Medical to Reinforce Its Hemodialyzer Assembly Plant in China.
Asahi Kasei Pharma, CoTherix Conclude Licensing Agreement for Fasudil, Rho-kinase Inhibitor.
Asahi Kasei Announces New Plant for Compound Semiconductor Wafer Processing.
Asahi Kasei's 'Microza' Selected for Largest-scale Waterworks in the US.
Asahi Kasei Reports Consolidated Third Quarter Results; Net Sales Rise 8.8%, Net Profit Rises 22%.
Asahi Kasei Announces Revision of Plan for Year-end Dividend.
Asahi Kasei Announces Commercial Start-up of Propane-process Acrylonitrile Line.
Asahi Kasei Establishes Chinese Subsidiary to Serve as Regional Headquarters.
Asahi Kasei Announces Consolidated Full Year Results; Net Sales Rise 8.4%, Net Income Rises 15%.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles